Other Pain Related News

10/13/2008	King Pharmaceuticals Extends Tender Offer
9/26/2008	King Pharmaceuticals Responds to Alpharma Inc.
9/11/2008	King to Commence Cash Tender Offer for Alpharma at $37 Per Share
8/22/2008	King Pharmaceuticals Provides Updated Replay Information for Conference Call Regarding Proposed Acquisition of Alpharma
8/22/2008	King Proposes Acquisition of Alpharma for $33 Per Share in Cash
8/6/2008	King Pharmaceuticals Supports Time To Talk(™) Education Campaign

• About Us

  • Vision
  • Who We Are
  • Why Choose King?
  • Strategy
  • Fast Facts
• Products

  • Avinza® CII
  • Skelaxin®
  • Thrombin-JMI®
  • Altace®
  • Sonata® CIV
  • Levoxyl®
  • Meridian Auto injector Products/EpiPen®
  • Alphabetic Listing of Products
  • NDC Listing of Products
  • Authorized Distributors of Record
• Investors

  • News Releases
  • Annual Report
  • SEC Documents
  • SEC Section 16 Reports
  • Governance
  • Webcasts
• Business Development
• Careers

  • Job Search
  • Benefits
  • Culture and Diversity
  • Why Choose King?
  • Locations
• Community

  • Community Investment Program
  • Medical Education Grants